Congratulations to Prof. Dominik Schneidawind and his team!
Congratulations to Prof. Dominik Schneidawind and co-workers for receiving a competitive Swiss Cancer League grant, entitled “Evaluation of pragmatic geriatric assessment for the prediction of toxicity and outcomes in older patients scheduled for chimeric antigen receptor T-cell therapy or bispecific antibody therapy” !
